attivare

Attivare Therapeutics | AI-Driven Personalized Cancer Immunotherapy

attivare was founded in 2021, is headquartered in Natick, United States, lists 1–10 employees, and has $6.6M in recorded funding across 1 round.

Headquarters
Natick
Employees
1–10
Founded
2021
Business Model
B2B
Total Funding
$6.6M
Last Round
$6.6M GrantJan 2026
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 1 investor for this company. The full record is or through the API.

About

Attivare Therapeutics, Inc. is a pre-clinical stage biotechnology company based in Natick, Massachusetts, founded by scientists from the Wyss Institute for Biologically Inspired Engineering at Harvard University. The company develops personalized cancer immunotherapy using two proprietary platforms: ATTImmune and ATT-AI. ATTImmune is a mesoporous silica rod (MSR) biomaterial scaffold that creates a three-dimensional immunomodulatory microenvironment within the tumor.

Summary

attivare is a Biotech company based in Natick, United States, founded in 2021. It lists 1–10 employees. It has raised $6.6M in total across 1 round, most recently a $6.6M Grant round in Jan 2026. Investors include Bill & Melinda Gates Foundation.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

GrantGates Foundation Malaria Vaccine GrantJan 2026
$6.6M

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

attivare on Indexed.vc
<a href="https://indexed.vc/companies/attivare"><img src="https://indexed.vc/api/badge/company/attivare" alt="attivare on Indexed.vc" width="260" height="76" /></a>